Search results :


More information: STITCH, PubChem and possibly Wikipedia

ATC Code: L04AC05

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3
Nasopharyngitis very common, 8% 8% x x x
Arthralgia common x x x
Back pain common, 1% 1% x x x
Diarrhoea common, 2% 2% x x x
Dizziness common, 1% 1% x x x
Fatigue common, 3% 2% x x x
Headache common, 5% 3% x x x
Nausea common x x x
Upper respiratory tract infection common — 5% 5% x x x
Injection site pain common x x
Myalgia common, 1% 1% x x x
Viral upper respiratory tract infection common x
Injection site erythema common, 1% 1% x x x
Tooth infection common x x x
Oropharyngeal pain common x
Pruritus uncommon — 2% 1% x x x
Pharyngolaryngeal pain common, 1% 1% x x
Cellulitis uncommon, common x x x
Nasal congestion uncommon, common x x
Depression uncommon — 1% 1% x x x
Contusion uncommon x x
Rash postmarketing — common x x x
Facial paralysis uncommon x
Haemorrhage uncommon x x x
Herpes zoster uncommon x x x
Swelling uncommon x x x
Urticaria postmarketing — common x x x
Injection site reaction uncommon x x x
Pustular psoriasis postmarketing, uncommon x x x
Induration uncommon x x x
Anaphylactic shock postmarketing, rare x x x
Angioedema postmarketing, rare x x x
Hypersensitivity postmarketing — common x x x
Immune system disorder postmarketing x x x
Erythrodermic psoriasis postmarketing x
Anxiety x
Appendicitis x
Mental disorder x x
Breast cancer x
Neoplasm malignant x x x
Skin cancer x x
Cholecystitis x
Infection x x x
Connective tissue disorder x
Diverticulitis x x x
Gastroenteritis x
Gastrointestinal disorder x x
Haematoma x
Mediastinal disorder x x
Malignant melanoma x x x
Myocardial infarction x
Nervous system disorder x x
Osteomyelitis x
Pain x
Pneumonia x x
Cerebrovascular accident x
Tuberculosis x x
Urinary tract infection x
Viral infection x
Melanoma skin x x
Unspecified disorder of skin and subcutaneous tissue x
Sepsis x
Skin carcinoma x x x
Infestation NOS x x
Posterior reversible encephalopathy syndrome x


Information about indications was extracted from the indications and usage sections of the labels.


Side effects:38
Source:FDA Structured Product Label

ustekinumab / ustekinumab

Side effects:50

Color scheme:


    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    no frequency information
    not found on label